These outcomes show that the mechanisms underlying the benefits were that Dex pretreatment partly through inhibiting microglia to transform into the proinflammatory M1 polarization state and inactivating the TLR4/NF-kB pathway reduces inflammatory response attenuates the cognitive disorders from acute limb ischemia-reperfusion. The gene discussed is TLR4; the disease is limb ischemia.